<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02664857</url>
  </required_header>
  <id_info>
    <org_study_id>Vitamin D</org_study_id>
    <nct_id>NCT02664857</nct_id>
  </id_info>
  <brief_title>Vitamin D Supplementations and Postoperative Pain</brief_title>
  <official_title>Effect of Vitamin D Supplementation on Postoperative Pain and Sedation-agitation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cukurova University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cukurova University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, effect of vitamin D supplementation on postoperative pain and&#xD;
      sedation-agitation will investigate. Children with mental motor retardation between 7-17 age&#xD;
      which dental treatment will be performed under general anaesthesia will be included in this&#xD;
      study. 600 IU vitamin D will apply to group D per orally during 12 weeks. Group P will not&#xD;
      take anything during 12 weeks. At first day and end of the 12 weeks, serum vitamin D, calcium&#xD;
      level will evaluate. At the end of the 12 weeks general anaesthesia will be performed for&#xD;
      teeth check up, flouring, scaling polishing, tooth extraction, filling applications,&#xD;
      amputations, root canal treatment. After then postoperative pain, sedation and agitation will&#xD;
      be evaluate. All data will be statistically evaluate at the end of the study.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Vitamin D deficiency could seem in children with mental and motor retardation. Some&#xD;
      researches show that vitamin D supplementations can reduce pain. In this study, the&#xD;
      researchers aimed to show effect of vitamin D supplementation on postoperative pain and&#xD;
      sedation-agitation. These children which will be applied dental treatment under general&#xD;
      anaesthesia included in this study. All subjects randomly divided to the two groups. Every&#xD;
      group will include 30 subject. Group D included mentally retarded children which will take&#xD;
      daily 600 IU orally vitamin D supplementation during 12 weeks. In the other group(group P)&#xD;
      mentally retarded children will not take any supplementation during 12 week. At the first day&#xD;
      and last day(after 12 weeks) of study, blood sample will take from all subject. Serum vitamin&#xD;
      D, calcium level will evaluate in this sample at the end of the study. All samples will be&#xD;
      frozen and stored until testing. All children will be operated under general anaesthesia.&#xD;
      Propofol 2mg/kg, rocuronium 0,6 mg/kg will apply for anaesthesia induction. Anaesthesia will&#xD;
      maintain with sevoflurane and oxygen- nitrous oxide mixture. Non-communicating Children's&#xD;
      Pain Check-list and Ramsey sedation scale will apply all children after postoperative care&#xD;
      unit. All children will be evaluate every 15 minutes. After data collection, all data will be&#xD;
      analysed with statistically.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Actual">December 2020</completion_date>
  <primary_completion_date type="Actual">December 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Non-communicating Children's Pain Checklist - Postoperative Version</measure>
    <time_frame>At Postoperative period for first 1 hour</time_frame>
    <description>The subjects will evaluate per 15 minutes for 1 hour.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>vitamin D level</measure>
    <time_frame>At first day and end of the 12 weeks</time_frame>
    <description>Serum vitamin D level will evaluate At first day and end of the 12 weeks.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative sedation-agitation</measure>
    <time_frame>At postoperative first hour</time_frame>
    <description>At postoperative period, every 15 minutes up to 1 hour. Ramsey sedation scores will record.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>vitamin D</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>After per orally vitamin D supplementation during 12 weeks, serum Vitamin D level will evaluate with laboratory testing. 600 IU vitamin D will apply to 30 subject during 12 weeks. At first day end end of the 12 weeks serum vitamin D level will analyse with laboratory testing.End of the 12 weeks, the children will be perform dental treatment under general anaesthesia. Postoperative pain, anxiety and sedation will evaluate.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Grup P will not take vitamin D during 12 weeks. This group just only will follow by researchers.At first day end end of the 12 weeks serum vitamin D level will analyse with laboratory testing.End of the 12 weeks, the children will be perform dental treatment under general anaesthesia. Postoperative pain, anxiety and sedation will evaluate.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin D</intervention_name>
    <description>Group D will take 600 IU vitamin D per orally during 12 weeks. At first day and end of the 12 weeks serum vitamin D level will analyse with laboratory testing</description>
    <arm_group_label>vitamin D</arm_group_label>
    <other_name>vitamin D supplementation</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Group P will not take orally during 12 weeks. This group will only observe by researchers.</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Observed group</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Mentally and motor retarded children&#xD;
&#xD;
          -  dental treatment under general anaesthesia&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  normally children(not MMR)&#xD;
&#xD;
          -  The persons who not accept the including study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>7 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dilek Ozcengiz, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>Cokurova University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cukurova University</name>
      <address>
        <city>Adana</city>
        <zip>01380</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 20, 2016</study_first_submitted>
  <study_first_submitted_qc>January 22, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 27, 2016</study_first_posted>
  <last_update_submitted>April 20, 2021</last_update_submitted>
  <last_update_submitted_qc>April 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cukurova University</investigator_affiliation>
    <investigator_full_name>ebru biricik</investigator_full_name>
    <investigator_title>Medical Doctor</investigator_title>
  </responsible_party>
  <keyword>Vitamin D</keyword>
  <keyword>Postoperative Pain</keyword>
  <keyword>Mental Motor Retardation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Vitamins</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

